Papers
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7305.131 (Published 21 July 2001) Cite this as: BMJ 2001;323:131
Related articles
- This Week In The BMJ Published: 21 July 2001; BMJ 323 doi:10.1136/bmj.323.7305.0/b
- Editorial Published: 21 July 2001; BMJ 323 doi:10.1136/bmj.323.7305.119
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2151
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2139
- Research Published: 07 August 2012; BMJ 345 doi:10.1136/bmj.e4944
- Research Published: 12 September 2013; BMJ 347 doi:10.1136/bmj.f5298
- Letter Published: 16 April 2013; BMJ 346 doi:10.1136/bmj.f2369
See more
- Weight loss drugs could make oral contraception less effective, MHRA warnsBMJ June 05, 2025, 389 r1169; DOI: https://doi.org/10.1136/bmj.r1169
- US abortion restrictions are keeping brain dead pregnant woman on life supportBMJ May 30, 2025, 389 r1120; DOI: https://doi.org/10.1136/bmj.r1120
- Brazil’s teen pregnancy rate is plummeting: what can other countries learn from it?BMJ May 30, 2025, 389 r852; DOI: https://doi.org/10.1136/bmj.r852
- Doctors’ leaders condemn police advice to search for abortion drugs after pregnancy lossBMJ May 20, 2025, 389 r1036; DOI: https://doi.org/10.1136/bmj.r1036
- ABC programme to reduce brain injury in childbirth will be rolled out in EnglandBMJ May 13, 2025, 389 r982; DOI: https://doi.org/10.1136/bmj.r982
Cited by...
- Location-specific risk factors for intracerebral hemorrhage: Systematic review and meta-analysis
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)
- Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability
- FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception
- Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills
- The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study
- Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen
- Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
- Authors' reply to Costescu and Waddington
- Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
- Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
- Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism
- Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
- Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
- Risk Factors for Venous Thromboembolism
- The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
- Contraception in Women with Medical Problems
- Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives
- Conjugated Equine Estrogen, Esterified Estrogen, Prothrombotic Variants, and the Risk of Venous Thrombosis in Postmenopausal Women
- Role of Genetic Analyses in Cardiology: Part II: Heritability Estimation for Gene Searching in Multifactorial Diseases
- Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial
- Venous Thrombosis: The Role of Genes, Environment, and Behavior
- British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
- Pharmaceutical industry sponsorship and research outcome and quality: systematic review
- Diane-35 (cyproterone acetate): safety concerns
- Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study
- Oral contraceptives, venous thromboembolism, and the courts
- Western medicine: a confidence trick driven by the drug industry?
- Hormone Replacement Therapy and the Factor V Leiden Mutation
- Female Hormones and Thrombosis
- Hypercoagulability: Too Many Tests, Too Much Conflicting Data
- Third-Generation Oral Contraceptives and VTE: A Reanalysis
- The third generation pill controversy (""continued"")